Seratrodast

CAS No. 112665-43-7

Seratrodast( AA2414 | A-73001 | ABT-001 )

Catalog No. M10444 CAS No. 112665-43-7

Seratrodast (INN) is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist used primarily in the treatment of asthma.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 35 In Stock
10MG 32 In Stock
25MG 58 In Stock
50MG 79 In Stock
100MG 114 In Stock
200MG Get Quote In Stock
500MG 276 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Seratrodast
  • Note
    Research use only, not for human use.
  • Brief Description
    Seratrodast (INN) is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist used primarily in the treatment of asthma.
  • Description
    Seratrodast (INN) is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist used primarily in the treatment of asthma. It was the first TP receptor antagonist that was developed as an anti-asthmatic drug and received marketing approval in Japan in 1997.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    AA2414 | A-73001 | ABT-001
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX| TXA2R
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    112665-43-7
  • Formula Weight
    354.44
  • Molecular Formula
    C22H26O4
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in Water
  • SMILES
    O=C(O)CCCCCC(C(C1=O)=C(C)C(C(C)=C1C)=O)C2=CC=CC=C2
  • Chemical Name
    (+-)-7-(3,5,6-Trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Endo S, Akiyama K. Nihon Rinsho. 1996 Nov;54(11):3045-8.
molnova catalog
related products
  • Sifalimumab

    Sifalimumab (MEDI-545) is a monoclonal antibody that targets IFNα and suppresses abnormal immune activity by binding to interferon-alpha.Sifalimumab is used for the treatment of moderate to severe SLE.

  • Tetrahydroamentoflav...

    Tetrahydroamentoflavone is a potent XO inhibitor (IC50 = 92 nM, Ki = 982 nM) with anti-inflammatory effects. Tetrahydroamentoflavone can be used for studies about inflammation and gout.

  • Parecoxib sodium

    A potent and selective COX-2 inhibitor; a water-soluble prodrug of valdecoxib.